MyOme Launches their Rare Disease Product Portfolio at ACMG 2025
Advancing Rare Disease Diagnostics with Whole Genome Insights MyOme, a leader in clinical whole-genome analysis and polygenic risk scores, is pleased to announce the launch of its rare disease diagnostic offering at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting on March 19, 2025. This milestone marks MyOme's first diagnostic product, part […]